ZA200209418B - Gabapentin analogous for sleep disorders. - Google Patents

Gabapentin analogous for sleep disorders. Download PDF

Info

Publication number
ZA200209418B
ZA200209418B ZA200209418A ZA200209418A ZA200209418B ZA 200209418 B ZA200209418 B ZA 200209418B ZA 200209418 A ZA200209418 A ZA 200209418A ZA 200209418 A ZA200209418 A ZA 200209418A ZA 200209418 B ZA200209418 B ZA 200209418B
Authority
ZA
South Africa
Prior art keywords
aminomethyl
acetic acid
cyclopentyl
methyl
cyclobutyl
Prior art date
Application number
ZA200209418A
Other languages
English (en)
Inventor
Justin Stephen Bryans
Leonard Theodore Meltzer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200209418B publication Critical patent/ZA200209418B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200209418A 2000-06-26 2002-11-19 Gabapentin analogous for sleep disorders. ZA200209418B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21417100P 2000-06-26 2000-06-26

Publications (1)

Publication Number Publication Date
ZA200209418B true ZA200209418B (en) 2005-03-10

Family

ID=22798045

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200209418A ZA200209418B (en) 2000-06-26 2002-11-19 Gabapentin analogous for sleep disorders.

Country Status (24)

Country Link
US (1) US7141606B2 (fr)
EP (1) EP1296671B1 (fr)
JP (1) JP3909842B2 (fr)
KR (1) KR100785182B1 (fr)
CN (1) CN1279900C (fr)
AT (1) ATE390133T1 (fr)
AU (2) AU2001264736B2 (fr)
BR (1) BR0111913A (fr)
CA (1) CA2414008C (fr)
CZ (1) CZ20024110A3 (fr)
DE (1) DE60133389T2 (fr)
DK (1) DK1296671T3 (fr)
ES (1) ES2300332T3 (fr)
HK (1) HK1056681A1 (fr)
HU (1) HUP0300833A3 (fr)
IL (2) IL152770A0 (fr)
MX (1) MXPA02010668A (fr)
NZ (1) NZ522480A (fr)
PL (1) PL359872A1 (fr)
PT (1) PT1296671E (fr)
SK (1) SK17922002A3 (fr)
TW (1) TWI298020B (fr)
WO (1) WO2002000209A2 (fr)
ZA (1) ZA200209418B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2444053C (fr) 2001-04-19 2008-06-17 Warner-Lambert Company Llc Acides amnines bicycliques ou tricycliques fondus
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7420002B2 (en) 2001-06-11 2008-09-02 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
EP1404324B2 (fr) 2001-06-11 2011-04-06 XenoPort, Inc. Promedicaments d'analogues de gaba, compositions et utilisations desdits promedicaments
WO2003077902A1 (fr) 2002-02-19 2003-09-25 Xenoport, Inc. Procede de synthese de promedicaments a partir de derives de 1-acyl-alkyl et compositions correspondantes
WO2003080588A1 (fr) 2002-03-20 2003-10-02 Xenoport Promedicaments 1-(acyloxy)-alkyle cyclique d'analogues de l'acide gamma-aminobutyrique, leurs compositions et leurs utilisations
US7183259B2 (en) 2002-05-17 2007-02-27 Xenoport Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
US7060727B2 (en) 2002-12-11 2006-06-13 Xenoport, Inc. Prodrugs of fused GABA analogs, pharmaceutical compositions and uses thereof
AU2003283718A1 (en) * 2002-12-13 2004-07-09 Warner-Lambert Company Llc Gabapentin analogues for fibromyalgia and other related disorders
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
WO2004093827A2 (fr) * 2003-03-25 2004-11-04 Kiel Laboratories, Inc. Sels d'acide phenolique de gabapentine en formes posologiques solides et procedes d'utilisation
EP1670451A4 (fr) 2003-09-11 2009-10-21 Xenoport Inc Traitement et/ou prevention de l'incontinence urinaire et promedicaments des analogues gaba
BRPI0414481A (pt) 2003-09-17 2006-11-14 Xenoport Inc métodos de tratamento ou de prevenção da sìndrome das pernas inquietas em um paciente e de melhoria do sono em um paciente com sìndrome das pernas inquietas, e, composição farmacêutica
KR101096480B1 (ko) 2003-10-14 2011-12-20 제노포트 인코포레이티드 감마-아미노부티르산 유사체의 결정질 형태
JP4613031B2 (ja) * 2004-05-06 2011-01-12 エスエス製薬株式会社 催眠剤組成物
JP2005325070A (ja) * 2004-05-14 2005-11-24 Ss Pharmaceut Co Ltd 睡眠改善剤
BRPI0517227B8 (pt) 2004-11-04 2021-05-25 Xenoport Inc comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido
JP2009505947A (ja) 2005-06-23 2009-02-12 エモリー・ユニバーシティ 画像化剤
KR20070070307A (ko) * 2005-08-24 2007-07-04 에스에스 세야쿠 가부시키 가이샤 수면 개선 의약 조성물
CA2640402C (fr) * 2006-03-06 2012-01-03 Pfizer Products Inc. Ligands alpha-2-delta pour sommeil non reparateur
EP2250148B1 (fr) 2008-01-25 2016-08-17 XenoPort, Inc. Forme cristalline de sels de calcium d'acide (3s)-aminomethyl-5-methyl-hexanoique et ses procedes d'utilisation
US7868043B2 (en) 2008-01-25 2011-01-11 Xenoport, Inc. Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
CA2706575C (fr) 2008-01-25 2015-07-14 Xenoport, Inc. Resolution des enantiomeres de thiocarbonates d'acyloxyalkyle utilises dans la synthese de precurseurs de carbamates d'acyloxyalkyle
AU2009302241B2 (en) 2008-10-08 2015-10-29 Xgene Pharmaceutical Inc. GABA conjugates and methods of use thereof
WO2011071995A2 (fr) 2009-12-08 2011-06-16 Case Western Reserve University Composés et procédés de traitement de troubles oculaires
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
AU2014209028C1 (en) 2013-01-28 2019-08-29 Hector L. Lopez Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
SG11201811368SA (en) * 2016-05-26 2019-01-30 Amino Up Chemical Co Ltd Sleep improving agent
WO2019219000A1 (fr) 2018-05-14 2019-11-21 Xgene Pharmaceutical Inc. Formes cristallines de conjugués de médicament 1- (acyloxy) -alkyle carbamate de naproxène et de prégabaline

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US5084479A (en) 1990-01-02 1992-01-28 Warner-Lambert Company Novel methods for treating neurodegenerative diseases
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5510381A (en) 1995-05-15 1996-04-23 Warner-Lambert Company Method of treatment of mania and bipolar disorder
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
DE69709070T2 (de) * 1996-03-14 2002-06-20 Warner Lambert Co Verbrückte zyklische aminosäuren als pharmazeutische mittel
US6372792B1 (en) * 1996-04-26 2002-04-16 Guy Chouinard Method for treating anxiety, anxiety disorders and insomnia
GEP20094817B (en) 1997-10-27 2009-11-10 Warner Lambert Co Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
NZ509231A (en) * 1998-07-09 2003-08-29 Warner Lambert Co Use of GABA analogs to treat insomnia
ES2185591T3 (es) * 1999-06-02 2003-05-01 Warner Lambert Co Amino hererociclos utiles como agentes farmaceuticos.
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
EP1237847B1 (fr) 1999-12-08 2006-05-17 Warner-Lambert Company Llc Methode de synthese stereoselective d'acides amines cycliques
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
DK1296671T3 (da) 2008-06-16
US7141606B2 (en) 2006-11-28
WO2002000209A2 (fr) 2002-01-03
JP2004501189A (ja) 2004-01-15
DE60133389D1 (de) 2008-05-08
EP1296671B1 (fr) 2008-03-26
KR20030019455A (ko) 2003-03-06
IL152770A0 (en) 2003-06-24
TWI298020B (en) 2008-06-21
HUP0300833A2 (hu) 2003-08-28
BR0111913A (pt) 2004-01-06
ES2300332T3 (es) 2008-06-16
CZ20024110A3 (cs) 2003-10-15
NZ522480A (en) 2005-06-24
CA2414008A1 (fr) 2002-01-03
JP3909842B2 (ja) 2007-04-25
AU2001264736B2 (en) 2006-04-27
MXPA02010668A (es) 2003-03-10
PL359872A1 (en) 2004-09-06
PT1296671E (pt) 2008-05-09
US20030212133A1 (en) 2003-11-13
SK17922002A3 (sk) 2003-11-04
DE60133389T2 (de) 2008-06-26
EP1296671A2 (fr) 2003-04-02
KR100785182B1 (ko) 2007-12-11
CA2414008C (fr) 2011-04-26
ATE390133T1 (de) 2008-04-15
WO2002000209A3 (fr) 2003-01-16
CN1279900C (zh) 2006-10-18
CN1436075A (zh) 2003-08-13
IL152770A (en) 2009-12-24
AU6473601A (en) 2002-01-08
HUP0300833A3 (en) 2009-08-28
HK1056681A1 (en) 2004-02-27

Similar Documents

Publication Publication Date Title
ZA200209418B (en) Gabapentin analogous for sleep disorders.
AU2001264736A1 (en) Gabapentin analogues for sleep disorders
CA1298201C (fr) Methode et compositions pour le traitement de l'obesite, de la depression, de la toxicomanie et de la narcolepsie
HU225534B1 (en) Pharmaceutical compositions comprising mirtazapine and one or more selective serotonin reuptake inhibitors
IE58314B1 (en) Pharmaceutical products providing enhanced analgasia
JPH03170421A (ja) 食欲を減退させるための方法および組成物
AU2002340971B2 (en) Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
SK284923B6 (sk) Zmes liečiv s antidepresívnym účinkom obsahujúca 2-amino-4,5,6,7- tetrahydro-6-propylaminobenzotiazol a sertralín a jej použitie
JPH06502148A (ja) 抗うつ剤
CA3119909A1 (fr) Procede de traitement de l'hypertension arterielle pulmonaire et de l'hypertension arterielle pulmonaire associee
US3557292A (en) Compositions and methods for treating parkinson's disease with combinations of l-3,4-dihydroxyphenylalanine and a hydrazine
US5541227A (en) Ibuprofen-containing medicament
KR20020060192A (ko) Nk₁ 수용체 길항제와 gaba 구조유사체의 상승적배합물
CA1248454A (fr) Composes medicamentaux de cytidil-diphosphocholine et procede de production
US4278667A (en) Method of treating tardive dyskinesia by oral dosage form of a physostigmine compound
US3932652A (en) Antidepressant compositions
NZ525623A (en) Pharmaceutical composition containing gaba analogs and an antiviral agent to treat shingles
US4716177A (en) Tolrestat for inhibition of weight gain
US3686409A (en) Combination of l-dopa and 2-imino-5-phenyl-4-oxazolidinone used to treat parkinson{40 s disease
CA1228301A (fr) Methode et compose pour le traitement des troubles neurologiques et du vieillissement
AU2007222112A1 (en) Alpha-2-delta ligands for non-restorative sleep
EP0003353A1 (fr) Composition pharmaceutique pour administration par voie orale pour le traitement de l'hypertension
HU202111B (en) Process for producing pharmaceutical compositions containing (r)-(e)-4--(3-phosphono-2-propenyl)-2-piperazine-carboxylic acid as active component
Kaye et al. Pharmacologic Adjuncts to Neurologic Rehabilitation
NZ509230A (en) Use of GABA analogs to treat renal colic